How Insulin May Be Silencing Your GLP-1
More Knowledge, Better Health
April 13, 2026
33 min
145
Full
145 of 155

Episode 145 · April 13, 2026
How Insulin May Be Silencing Your GLP-1
0:00 / 33:56
Excerpt playback isn’t available for this episode — use the full-episode link.
Search the Record
Moment search isn’t open for this episode yet
When it opens, you’ll be able to type any phrase and jump straight to the second it was said.
Ben Bikman Episodes Around April 13, 2026
Episode 145 of 155 — walk the feed in the order it was published.
33:56This episodeHow Insulin May Be Silencing Your GLP-1
Summary
<p>📢 Ask Dr. Bikman’s Digital Mind (multilingual):</p><p><a href="https://benbikman.com/ben-bikmans-digital-ai-mind" rel="noopener noreferrer" target="_blank">https://benbikman.com/ben-bikmans-digital-ai-mind</a></p><br /><p>📢 Dr. Bikman’s Community & Coaching Site: <a href="https://insuliniq.com" rel="noopener noreferrer" target="_blank">https://insuliniq.com</a></p><br /><p>Summary:</p><p>GLP-1 has become one of the most talked-about hormones in modern medicine, largely due to the rise of GLP-1 receptor agonist drugs for weight loss. In this lecture, Dr. Ben Bikman shifts the focus from how GLP-1 affects insulin to the overlooked reverse question: how insulin affects GLP-1. That shift reveals a deeper metabolic story about how chronic hyperinsulinemia may impair the body’s ability to produce GLP-1 over time.</p><br /><p>Dr. Bikman first clarifies a key misconception. While GLP-1 can stimulate insulin under artificial conditions, in a real meal its dominant role is to slow gastric emptying, suppress glucagon, and reduce the need for insulin. In that sense, GLP-1 functions primarily as an insulin-sparing hormone. This makes the reverse question critical: what happens when the body produces less GLP-1?</p><br /><p>Evidence shows that insulin-resistant, obese, prediabetic, and type 2 diabetic individuals consistently have a blunted GLP-1 response. Mechanistic studies indicate that chronic exposure to high insulin can make L-cells insulin resistant, reducing their ability to secrete GLP-1 when needed. This may create a vicious cycle: high insulin suppresses GLP-1, low GLP-1 removes metabolic brakes, and the resulting larger glucose and insulin spikes further worsen the problem over time.</p><br /><p>The lecture reframes GLP-1 deficiency as a potential consequence of chronic hyperinsulinemia rather than an isolated defect. While GLP-1 drugs can bypass this dysfunction and improve outcomes, they do not repair the underlying cause—making long-term strategies that lower chronically elevated insulin levels more fundamental.</p><br /><p>References:</p><p>For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: <a href="https://www.benbikman.com" rel="noopener noreferrer" target="_blank">https://www.benbikman.com</a></p><br /><p>NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.</p><hr /><p style="color: grey; font-size: 0.75em;"> Hosted on Acast. See <a href="https://acast.com/privacy" rel="noopener noreferrer" style="color: grey;" target="_blank">acast.com/privacy</a> for more information.</p>
























